{"component": "definition", "props": {"groups": [{"snippet": "means the shares of Common Stock issuable upon conversion of the Notes.", "samples": [{"hash": "hxyj9XUgEKQ", "uri": "/contracts/hxyj9XUgEKQ#note-shares", "label": "Securities Purchase Agreement (ZyVersa Therapeutics, Inc.)", "score": 37.1724853516, "published": true}, {"hash": "xKpcpnXNV5", "uri": "/contracts/xKpcpnXNV5#note-shares", "label": "Note Purchase Agreement (Eterna Therapeutics Inc.)", "score": 35.7323760986, "published": true}, {"hash": "jTuWfQTFn4R", "uri": "/contracts/jTuWfQTFn4R#note-shares", "label": "Securities Purchase Agreement (Comera Life Sciences Holdings, Inc.)", "score": 34.9904174805, "published": true}], "size": 96, "snippet_links": [{"key": "conversion-of-the-notes", "type": "clause", "offset": [47, 70]}], "hash": "e44dea7ccc4faf9063d7bc8d94da4750", "id": 1}, {"snippet": "has the meaning given such term in Section 12(a).", "samples": [{"hash": "lpH1VA2H6M3", "uri": "/contracts/lpH1VA2H6M3#note-shares", "label": "Security and Purchase Agreement (Miscor Group, Ltd.)", "score": 21.0, "published": true}, {"hash": "lMrMCTvQN5I", "uri": "/contracts/lMrMCTvQN5I#note-shares", "label": "Security Agreement (Accentia Biopharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "kr5JHhDWsiv", "uri": "/contracts/kr5JHhDWsiv#note-shares", "label": "Security Agreement (ProLink Holdings Corp.)", "score": 21.0, "published": true}], "size": 55, "snippet_links": [], "hash": "957dd1354a40de17c2803bfb3ffbdf1a", "id": 2}, {"snippet": "means the shares of Common Stock issuable upon conversion of a Note, including any outstanding principal and accrued interest.", "samples": [{"hash": "kQd5WKJH4io", "uri": "/contracts/kQd5WKJH4io#note-shares", "label": "Convertible Note (Odyssey Semiconductor Technologies, Inc.)", "score": 35.1984939575, "published": true}, {"hash": "hB3Jvhkv5Iz", "uri": "/contracts/hB3Jvhkv5Iz#note-shares", "label": "Convertible Note (Odyssey Semiconductor Technologies, Inc.)", "score": 35.1984939575, "published": true}, {"hash": "cC0HBd3OrmG", "uri": "/contracts/cC0HBd3OrmG#note-shares", "label": "Convertible Note (Odyssey Semiconductor Technologies, Inc.)", "score": 35.1984939575, "published": true}], "size": 23, "snippet_links": [{"key": "conversion-of", "type": "clause", "offset": [47, 60]}, {"key": "a-note", "type": "clause", "offset": [61, 67]}, {"key": "outstanding-principal", "type": "clause", "offset": [83, 104]}, {"key": "accrued-interest", "type": "clause", "offset": [109, 125]}], "hash": "ee225182157ebae190c7824d7f429374", "id": 3}, {"snippet": "has the meaning set forth in the Recitals.", "samples": [{"hash": "aArUI4Q7nDs", "uri": "/contracts/aArUI4Q7nDs#note-shares", "label": "Note Purchase and Registration Rights Agreement (Venus Concept Inc.)", "score": 35.0479125977, "published": true}, {"hash": "bmAlmYbALf1", "uri": "/contracts/bmAlmYbALf1#note-shares", "label": "Securities Purchase Agreement (Fennec Pharmaceuticals Inc.)", "score": 33.9144439697, "published": true}, {"hash": "dTiUEtfaSZY", "uri": "/contracts/dTiUEtfaSZY#note-shares", "label": "Securities Purchase Agreement (Fennec Pharmaceuticals Inc.)", "score": 33.5804252625, "published": true}], "size": 6, "snippet_links": [{"key": "the-recitals", "type": "clause", "offset": [29, 41]}], "hash": "8147307746bce1e7e7ce0d9d9441a89a", "id": 4}, {"snippet": "has the meaning set forth in Section 4.5(a) of this Agreement;", "samples": [{"hash": "hgGwuW9id2h", "uri": "/contracts/hgGwuW9id2h#note-shares", "label": "Note Purchase Agreement (BELLUS Health Inc.)", "score": 21.0, "published": true}, {"hash": "gZGqrQn11NA", "uri": "/contracts/gZGqrQn11NA#note-shares", "label": "Note Purchase Agreement (BELLUS Health Inc.)", "score": 21.0, "published": true}, {"hash": "byeUyQhmxMg", "uri": "/contracts/byeUyQhmxMg#note-shares", "label": "Note Purchase Agreement (BELLUS Health Inc.)", "score": 21.0, "published": true}], "size": 6, "snippet_links": [{"key": "this-agreement", "type": "clause", "offset": [47, 61]}], "hash": "2be0aca75e56bc1cce732993dd6ed0d1", "id": 5}, {"snippet": "has the meaning set forth in Section 3.1(w).", "samples": [{"hash": "ajuKYAw78C9", "uri": "/contracts/ajuKYAw78C9#note-shares", "label": "Exchange Agreement and Amendment to Facility Agreement (Kempharm, Inc)", "score": 30.9603004456, "published": true}, {"hash": "8MUjlWptNVK", "uri": "/contracts/8MUjlWptNVK#note-shares", "label": "Facility Agreement (Kempharm, Inc)", "score": 25.9637241364, "published": true}], "size": 5, "snippet_links": [], "hash": "b0d99f5d9991cbeb7c866f4b3e9a6171", "id": 6}, {"snippet": "means the 1,600,000 shares of the Company's Series B Convertible Preferred Stock, $.01 par value per share, issued pursuant to the Conversion Agreement.", "samples": [{"hash": "gH7TaQY88JD", "uri": "/contracts/gH7TaQY88JD#note-shares", "label": "Stock Purchase Agreement (Apollon Inc)", "score": 18.0, "published": true}, {"hash": "31N8WW8BEk7", "uri": "/contracts/31N8WW8BEk7#note-shares", "label": "Common Stock Warrant (Apollon Inc)", "score": 18.0, "published": true}, {"hash": "7uTWLyU2123", "uri": "/contracts/7uTWLyU2123#note-shares", "label": "Series B Stock Purchase Agreement (Apollon Inc)", "score": 15.0, "published": true}], "size": 4, "snippet_links": [{"key": "shares-of-the-company", "type": "clause", "offset": [20, 41]}, {"key": "series-b-convertible-preferred-stock", "type": "definition", "offset": [44, 80]}, {"key": "par-value-per-share", "type": "clause", "offset": [87, 106]}, {"key": "conversion-agreement", "type": "definition", "offset": [131, 151]}], "hash": "3c119d879457eaf80b28ecff3422eeb9", "id": 7}, {"snippet": "means the shares of Common Stock issuable upon conversion of the Commitment Note.", "samples": [{"hash": "3X2oDIoIt60", "uri": "/contracts/3X2oDIoIt60#note-shares", "label": "Equity Purchase Agreement (Futureland Corp.)", "score": 27.2751541138, "published": true}, {"hash": "cfnM1CFgDLJ", "uri": "/contracts/cfnM1CFgDLJ#note-shares", "label": "Equity Purchase Agreement (MyDx, Inc.)", "score": 27.1054077148, "published": true}, {"hash": "2zybVTfhpBF", "uri": "/contracts/2zybVTfhpBF#note-shares", "label": "Equity Purchase Agreement (OWC Pharmaceutical Research Corp.)", "score": 26.9739894867, "published": true}], "size": 3, "snippet_links": [{"key": "conversion-of", "type": "clause", "offset": [47, 60]}, {"key": "commitment-note", "type": "clause", "offset": [65, 80]}], "hash": "7a113b4368ec7f0f1db24d28577151f7", "id": 8}, {"snippet": "means the Ordinary Shares acquired by the Investor upon conversion of the Note.", "samples": [{"hash": "9jwk0cdnaGp", "uri": "/contracts/9jwk0cdnaGp#note-shares", "label": "Registration Rights Agreement (Kongzhong Corp)", "score": 21.0, "published": true}, {"hash": "61l3QywDbi5", "uri": "/contracts/61l3QywDbi5#note-shares", "label": "Note and Warrant Purchase Agreement (Kongzhong Corp)", "score": 21.0, "published": true}, {"hash": "j4X5yGsi899", "uri": "http://services.corporate-ir.net/SEC/Document.Service?id=P3VybD1hSFIwY0RvdkwyRndhUzUwWlc1cmQybDZZWEprTG1OdmJTOWtiM2R1Ykc5aFpDNXdhSEEvWVdOMGFXOXVQVkJFUmlacGNHRm5aVDAyTWpnNE9ERTRKbk4xWW5OcFpEMDFOdz09JnR5cGU9MiZmbj1Lb25nWmhvbmdDb3JwLnBkZg==", "label": "services.corporate-ir.net", "score": 10.1704311371, "published": false}], "size": 3, "snippet_links": [{"key": "shares-acquired", "type": "clause", "offset": [19, 34]}, {"key": "by-the-investor", "type": "clause", "offset": [35, 50]}, {"key": "conversion-of-the-note", "type": "clause", "offset": [56, 78]}], "hash": "d51da769c99191e4649df2339527ce32", "id": 9}, {"snippet": "means those XCel Shares issuable upon conversion of the Promissory Notes.", "samples": [{"hash": "7UnFM6nI9DC", "uri": "/contracts/7UnFM6nI9DC#note-shares", "label": "Asset Purchase Agreement (XCel Brands, Inc.)", "score": 25.2683086395, "published": true}, {"hash": "hXfSaCm5PHA", "uri": "http://ir.xcelbrands.com/static-files/e8c565b8-acf2-448e-a2fc-c01a51e91217", "label": "ir.xcelbrands.com", "score": 10.1704311371, "published": false}, {"hash": "4ZtZPkW7sks", "uri": "https://ir.xcelbrands.com/static-files/e8c565b8-acf2-448e-a2fc-c01a51e91217", "label": "ir.xcelbrands.com", "score": 9.96235466, "published": false}], "size": 3, "snippet_links": [{"key": "conversion-of", "type": "clause", "offset": [38, 51]}, {"key": "the-promissory-notes", "type": "clause", "offset": [52, 72]}], "hash": "af93afb9f4db81d909e37b4b2baae614", "id": 10}], "next_curs": "ClgSUmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIUbm90ZS1zaGFyZXMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means the shares of Common Stock issuable upon conversion of the Notes.", "title": "Note Shares", "size": 285, "id": "note-shares", "examples": ["The Company agrees that no medallion guarantee (or other type of guarantee or notarization) shall be required to remove a legend from any <strong>Note Shares</strong>.", "As used herein, \u201cStandard Settlement Period\u201d means the standard settlement period, expressed in a number of Trading Days, on the Company\u2019s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate (or book-entry notation) representing <strong>Note Shares</strong>, issued with a restrictive legend.", "The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the <strong>Note Shares</strong>, and will take such other action as is necessary to cause all of the <strong>Note Shares</strong> to be listed or quoted on such other Trading Market as promptly as possible.", "The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the <strong>Note Shares</strong> on such Trading Market and promptly secure the listing of all of the <strong>Note Shares</strong> on such Trading Market.", "If the Company does not have a sufficient number of Common Stock available to honor the conversion of the Note, the Company shall allocate the available number of <strong>Note Shares</strong> on a pro rata basis among all Purchasers converting the Note, until such time as the Company has a sufficient number of authorized shares of Common Stock to issue all <strong>Note Shares</strong> in full.", "The <strong>Note Shares</strong>, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable (which means that no further sums are required to be paid by the holders thereof in connection with the issue thereof), free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents and applicable law.", "As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of Common Stock for the purpose of enabling the Company to issue the maximum number of <strong>Note Shares</strong> pursuant to any conversion of the Note (as adjusted for forward and reverse share splits, recapitalizations, share dividends and the like after the date hereof).", "The Company shall honor conversions of the Note and shall deliver <strong>Note Shares</strong> in accordance with the terms, conditions and time periods set forth in the Transaction Documents."], "related": [["conversion-shares", "Conversion Shares", "Conversion Shares"], ["convertible-debentures", "Convertible Debentures", "Convertible Debentures"], ["pipe-shares", "PIPE Shares", "PIPE Shares"], ["conversion-securities", "Conversion Securities", "Conversion Securities"], ["series-c-shares", "Series C Shares", "Series C Shares"]], "related_snippets": [], "updated": "2026-07-26T04:22:51+00:00"}, "json": true, "cursor": ""}}